EA201991866A1 - COMBINED THERAPY - Google Patents

COMBINED THERAPY

Info

Publication number
EA201991866A1
EA201991866A1 EA201991866A EA201991866A EA201991866A1 EA 201991866 A1 EA201991866 A1 EA 201991866A1 EA 201991866 A EA201991866 A EA 201991866A EA 201991866 A EA201991866 A EA 201991866A EA 201991866 A1 EA201991866 A1 EA 201991866A1
Authority
EA
Eurasian Patent Office
Prior art keywords
combined therapy
diseases
treatment
combination
therapy
Prior art date
Application number
EA201991866A
Other languages
Russian (ru)
Inventor
Бенуа Ноэль
Роберт Вальчак
Кароль Беланже
Original Assignee
Женфит
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Женфит filed Critical Женфит
Priority claimed from PCT/EP2018/054305 external-priority patent/WO2018153933A1/en
Publication of EA201991866A1 publication Critical patent/EA201991866A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients

Abstract

Настоящее изобретение относится к комбинации активных ингредиентов для применения в лечении заболеваний.The present invention relates to a combination of active ingredients for use in the treatment of diseases.

EA201991866A 2017-04-05 2018-02-21 COMBINED THERAPY EA201991866A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17165131 2017-04-05
PCT/EP2018/054305 WO2018153933A1 (en) 2017-02-21 2018-02-21 Combination of a ppar agonist with a fxr agonist

Publications (1)

Publication Number Publication Date
EA201991866A1 true EA201991866A1 (en) 2020-01-30

Family

ID=58489658

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201991866A EA201991866A1 (en) 2017-04-05 2018-02-21 COMBINED THERAPY

Country Status (1)

Country Link
EA (1) EA201991866A1 (en)

Similar Documents

Publication Publication Date Title
EA201790273A1 (en) FLAGELLIN COMPOSITIONS AND THEIR APPLICATION
PH12016501139A1 (en) Bicyclic heterocycle compounds and their uses in therapy
MX2020001513A (en) Clec9a binding agents and use thereof.
EA201991484A1 (en) MEDICINAL FORMS OF ENZALUTAMIDE
MX2020009780A (en) Autotaxin inhibitor compounds.
EA202092456A2 (en) COMBINATION THERAPY INCLUDING MDM2 INHIBITOR AND ONE OR MORE ADDITIONAL PHARMACEUTICALLY ACTIVE AGENTS FOR TREATMENT OF VARIOUS TYPES OF CANCER
EA201691481A1 (en) C5a inhibitors for the treatment of viral pneumonia
EA201991997A1 (en) COMBINED THERAPY
CO2019007205A2 (en) Therapeutic uses of an insect powder
ZA201906100B (en) Combination of a ppar agonist with a fxr agonist
EA201690039A1 (en) RORC2 INHIBITORS AND METHODS OF THEIR APPLICATION
EA201892265A1 (en) METHODS OF TREATMENT OF OPHTHALMIC DISEASES
PH12018502161A1 (en) Methods of treatment for cholestatic and fibrotic diseases
EA201792571A1 (en) THERAPEUTIC APPLICATION OF L-4-CHLOROKINURENIN
EA201792560A1 (en) NANOPARTICLES FOR APPLICATION AS A THERAPEUTIC VACCINE
EA202090266A1 (en) MPO INHIBITORS FOR MEDICAL USE
PH12019501820A1 (en) Pharmaceutical compositions for combination therapy
EA201992389A1 (en) SUBSTITUTED N-ARILETHYL-2-AMINOCHINOLIN-4-CARBOXAMIDES AND THEIR APPLICATION
EA201790020A1 (en) COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATION IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
EA201991866A1 (en) COMBINED THERAPY
MX2018015240A (en) Compositions comprising timolol and their use in the treatment of rosacea by topical administration.
PH12017501693A1 (en) Compositions for the treatment of kidney and/or liver diseases
MX2018006631A (en) Compound for use in the prevention and treatment of neurodegenerative diseases.
EA201592012A1 (en) APPLICATION OF FLAGELLIN FOR IMPROVED CHEMOTHERAPY
TR201716203A1 (en) New umeclidinium formulations.